Quidel Corporation

Quidel Corporation (Nasdaq: QDEL) is a California-based manufacturer of diagnostic healthcare solutions serving to enhance the health and well being of people around the globe through the development of diagnostic solutions that can lead to improved patient outcomes and provide economic benefits to the healthcare system.

Quidel is 35 years young, with commercialized products in the healthcare market since 1984. Originally known for lateral flow products used in physician’s offices, our product lines have expanded through robust product development to include tests in infectious disease and reproductive health that are used in hospitals, reference labs, and clinics as well. Our current products fall generally into these categories: (1) lateral flow, where we are market leaders in infectious disease and reproductive health; (2) direct fluorescent antibodies (DFA), with expertise in infectious disease and virology; (3) micro-titer production, with a focus on bone and complement pathway markets; (4) fluorescent immunoassay products (Sofia); and (4) molecular diagnostic products.

Whether at our headquarters in San Diego, California, at our research and manufacturing operations in Ohio, Massachusetts, and Germany, or through our Commercial organization around the world, the Company is delivering a continuum of diagnostic solutions from advanced lateral-flow and direct fluorescent antibody testing to molecular diagnostic tests that further improve the quality of healthcare.

Type
Public
HQ
San Diego, US
Founded
1979
Size (employees)
627 (est)
Website
quidel.com
Quidel Corporation was founded in 1979 and is headquartered in San Diego, US

Quidel Corporation Office Locations

Quidel Corporation has an office in San Diego
San Diego, US (HQ)
200 12544 High Bluff Dr

Quidel Corporation Data and Metrics

Quidel Corporation Financial Metrics

Quidel Corporation's revenue was reported to be $191.6 m in FY, 2016 which is a 2% decrease from the previous period.
Numbers are in $, USD

Revenue (FY, 2016)

191.6 m

Revenue growth (FY, 2015 - FY, 2016), %

(2%)

Gross profit (FY, 2016)

118.2 m

Gross profit margin (FY, 2016), %

62%

Net income (FY, 2016)

(13.8 m)

EBIT (FY, 2016)

(4.4 m)

Market capitalization (26-May-2017)

827.1 m

Closing share price (26-May-2017)

24.9

Cash (31-Dec-2016)

169.5 m

EV

802 m
Quidel Corporation's current market capitalization is $827.1 m.
Numbers are in $, USDFY, 2014FY, 2015FY, 2016

Revenue

182.6 m196.1 m191.6 m

Revenue growth, %

4%7%(2%)

Cost of goods sold

74.2 m71.7 m73.4 m

Gross profit

108.4 m124.4 m118.2 m

Gross profit Margin, %

59%63%62%

Operating expense total

191.8 m193.4 m196 m

EBIT

(9.2 m)2.7 m(4.4 m)

EBIT margin, %

(5%)1%(2%)

Interest expense

1.8 m12 m11.8 m

Income tax expense

(3.9 m)(3.2 m)(2.4 m)

Net Income

(7.1 m)(6.1 m)(13.8 m)
Numbers are in $, USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

8.4 m200.9 m191.5 m169.5 m

Accounts Receivable

29.9 m34.5 m18.4 m25 m

Inventories

27.6 m24.8 m26.4 m26 m

Current Assets

78.6 m275.1 m240.7 m225.4 m

PP&E

48.1 m49.2 m52.5 m50.9 m

Goodwill

80.8 m80.7 m80.7 m83.8 m

Total Assets

271.5 m451.6 m406.5 m388.3 m

Accounts Payable

7 m12.4 m8.7 m16 m

Total Debt

142.1 m143.3 m144.3 m

Current Liabilities

24 m36.4 m30.8 m33.6 m

Additional Paid-in Capital

201 m229.4 m209.1 m204.9 m

Retained Earnings

22.7 m15.6 m9.6 m(4.3 m)

Total Equity

223.8 m245 m218.7 m200.6 m

Debt to Equity Ratio

0.6 x0.7 x0.7 x

Debt to Assets Ratio

0.3 x0.4 x0.4 x

Financial Leverage

1.2 x1.8 x1.9 x1.9 x
Numbers are in $, USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

7.4 m(7.1 m)(6.1 m)(13.8 m)

Accounts Receivable

2.9 m(4.5 m)16.1 m(6.3 m)

Inventories

(12 m)2.9 m(1.6 m)859 k

Accounts Payable

(651 k)4.4 m(3.1 m)4.3 m

Cash From Operating Activities

25.7 m35.7 m36.3 m11.8 m

Cash From Investing Activities

(33.9 m)(11.2 m)(17 m)(17 m)

Cash From Financing Activities

1.8 m168.1 m(28.7 m)(16.8 m)

Interest Paid

1.1 m981 k7 m6.5 m

Income Taxes Paid

2.2 m327 k1.9 m490 k
Numbers are in $, USDY, 2016

EV/EBIT

-180.7 x

EV/CFO

67.9 x

Revenue/Employee

307.1 k

Debt/Equity

0.7 x

Debt/Assets

0.4 x

Financial Leverage

1.9 x

Quidel Corporation Operating Metrics

FY, 2016

Facilities

2

Quidel Corporation Market Value History

Quidel Corporation Revenue Breakdown

Quidel Corporation Company Life and Culture

You may also be interested in